跳至主要内容
临床试验/NCT05286645
NCT05286645
已完成
不适用

Intervention Effect of High Definition Transcranial Direct Current Stimulation (HD-tDCS) on Depressive Disorder

Anhui Medical University1 个研究点 分布在 1 个国家目标入组 57 人2021年1月1日

概览

阶段
不适用
干预措施
High definition transcranial direct current stimulation
疾病 / 适应症
未指定
发起方
Anhui Medical University
入组人数
57
试验地点
1
主要终点
the change of somatic symptoms in active group and sham group at post-treatment and follow-up visit.
状态
已完成
最后更新
3个月前

概览

简要总结

To investigate the intervention effect of high definition transcranial direct current stimulation (HD-tDCS) on somatic symptoms in patients with depressive disorder and its underlying neural mechanism by MRI.

详细描述

Depressive disorder is a major public health and safety problem around the world. Patients with depression often performe symptoms such as anhedonia, lack of motivation, somatic symptoms, and even suicidal ideation and behavior. The purpose of this study was to study the relieving effect of high definition transcranial direct current stimulation (HD-tDCS) on the symptoms of depression. 60 patients with depressive disorder diagnosed by DSM-5 were recruited from the fourth people's Hospital of Hefei and the first affiliated Hospital of Anhui Medical University. All participants underwent a structured interview and routine laboratory examination before and after receiving HD-tDCS. After meeting the inclusion criteria and obtaining informed consent. Each participant will complete the clinical evaluation, functional magnetic resonance imaging (fMRI) and HD-tDCS treatment conducted by trained researchers at the Neuropsychological Synergetic Innovation Center of Anhui Medical University. All the participants were randomized (1:1) to receive "active" or "sham" treatment protocol. The anode was placed over Fz with return electrodes placed at Fpz, Cz, F3 and F4. Fourteen 2-mA sessions (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 20 minutes each day over 14 consecutive sessions. Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds. Before and after the HD-tDCS treatment, the patients had receiving a battery measure of neuropsychological tests and Magnetic resonance imaging scan in multimodalities. Neuropsychological assessment included MoCA, Stroop Test, VFT, DST, AVLT, HAMD, HAMA, PHQ15, BSS(Beck scale for suicide ideation),ISI,SDS, RRS, TEPS, AES, FPQ, PVAQ and AAS. Multimodal fMRI includes 3D-T1, rs-fMRI, DTI and ASL. Neuropsychological evaluation and magnetic resonance imaging data were obtained again 24 hours after the last treatment. The symptoms of the patients were followed up one month after the end of treatment.They were instructed to focus their answers on the past week. Afterwards, they were unblinded by the study coordinator.

注册库
clinicaltrials.gov
开始日期
2021年1月1日
结束日期
2024年8月31日
最后更新
3个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
Anhui Medical University
责任方
Principal Investigator
主要研究者

WANG KAI

Director of medical psychological department, Anhui Medical University

Anhui Medical University

入排标准

入选标准

  • the patients were diagnosed by more than 2 psychiatrists and met the diagnostic criteria of DSM-5 for depression, and HAMD\>17, PHQ-15\>
  • the age ranged from 18 to 60 years old
  • right-handed
  • stable dose of medication for at least 4 weeks or no history of antidepressive drugs before intervention

排除标准

  • accompanied by severe somatic diseases, such as severe heart, liver, renal insufficiency and so on.
  • accompanied by other neurological diseases, such as stroke, epilepsy and so on.
  • accompanied by other mental disorders, such as drug abuse, schizophrenia, schizophrenic affective disorder, hysteria, autism and so on.
  • patients with MRI taboos or factors affecting imaging quality, such as cardiac pacemaker, cochlear implant, cardio-cerebrovascular metal stent, metal denture, etc.
  • pregnancy and breastfeeding.
  • previous physical treatment (electroconvulsive therapy or tDCS).

研究组 & 干预措施

real stimulation

Participants will receive active tDCS once daily for two weeks. The anode was placed over Fz with return electrodes placed at Fpz, Cz, F3 and F4. Fourteen 2-mA sessions (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 20 minutes each day over 14 consecutive sessions.

干预措施: High definition transcranial direct current stimulation

sham stimulation

Participants will receive sham tDCS once daily for two weeks. Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.

干预措施: sham high definition transcranial direct current stimulation

结局指标

主要结局

the change of somatic symptoms in active group and sham group at post-treatment and follow-up visit.

时间窗: Baseline, Week 2 and Week 8.

the somatic symptoms were assessed by PHQ-15 scale.

the percentage decrease in PHQ-15 scores in active group and sham group at post-treatment and follow-up visit.

时间窗: Baseline, Week 2 and Week 8.

The percentage of decrease in scores was measured using the following formula: (pretreatment scores - post-treatment scores)/pretreatment scores × 100 %).

the number of somatic responders in active group and sham group at post-treatment and follow-up visit.

时间窗: Baseline, Week 2 and Week 8.

Responders were defined as patients who had a ≥ 50% decrease in the PHQ-15 score.

次要结局

  • the change of depressive symptoms in active group and sham group at post-treatment and follow-up visit.(Baseline, Week 2 and Week 8.)
  • the percentage decrease in HAMD scores in active group and sham group at post-treatment and follow-up visit.(Baseline, Week 2 and Week 8.)
  • the number of depressive responders in active group and sham group at post-treatment and follow-up visit.(Baseline, Week 2 and Week 8.)

研究点 (1)

Loading locations...

相似试验